Kyowa Hakko’s IMMUSE®, a clinically researched unique postbiotic, provides immune support in Lactoflor® Immuno 200...
Manufacturing strains of Kyowa Hakko Bio’s 3'-sialyllactose and 6’-sialyllactose, human milk oligosaccharides (HMOs), passed safety evaluation in China
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strains used for producing 3'-sialyllactose (3’-SL) and 6’-sialyllactose (6’-SL) have passed the Chinese Ministry of Agriculture and Rural affairs’ (MARA) safety evaluation...
KYOWA HAKKO BIO CO. LTD. (Kyowa Hakko Bio), a subsidiary of Kirin Holdings Company, Limited (Kirin Holdings), completed a production facility for human milk oligosaccharides (HMOs) on November 18, 2022 at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
The Kyowa Quality (KQ) brand consists of an extensive line of ultra-pure amino acids and related compounds supplied by KYOWA HAKKO BIO CO., LTD. (KYOWA), a global leader with over 60 years of manufacturing expertise and a reputation for rigorous quality assurance.